Merck standing pat on sales force size
"We're very comfortable with our numbers" of sales reps, Merck Senior Director-Investor Relations Laura Jordan told a July 24 conference call. Merck has the right size sales force "relative to our portfolio of marketed products and which physicians we call on, and which are the appropriate physicians to call on and which are the appropriate products to detail to those physicians," she said. After adding about 600 reps ahead of the Vioxx launch in 1999, Merck has a 5,000-person sales force: 4,000 are primary care sales reps and 1,000 are divided among about 10 specialty sales groups
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth